List of Chapters/Sections(Table Of Content)
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Therapeutic Radioisotopes Market Size Analysis from 2022 to 2027
1.5.1 Global Therapeutic Radioisotopes Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Therapeutic Radioisotopes Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Therapeutic Radioisotopes Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Therapeutic Radioisotopes Industry Impact
Chapter 2 Global Therapeutic Radioisotopes Competition by Types, Applications, and Top Regions and Countries
2.1 Global Therapeutic Radioisotopes (Volume and Value) by Type
2.1.1 Global Therapeutic Radioisotopes Consumption and Market Share by Type (2016-2021)
2.1.2 Global Therapeutic Radioisotopes Revenue and Market Share by Type (2016-2021)
2.2 Global Therapeutic Radioisotopes (Volume and Value) by Application
2.2.1 Global Therapeutic Radioisotopes Consumption and Market Share by Application (2016-2021)
2.2.2 Global Therapeutic Radioisotopes Revenue and Market Share by Application (2016-2021)
2.3 Global Therapeutic Radioisotopes (Volume and Value) by Regions
2.3.1 Global Therapeutic Radioisotopes Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Therapeutic Radioisotopes Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Therapeutic Radioisotopes Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Therapeutic Radioisotopes Consumption by Regions (2016-2021)
4.2 North America Therapeutic Radioisotopes Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Therapeutic Radioisotopes Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Therapeutic Radioisotopes Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Therapeutic Radioisotopes Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Therapeutic Radioisotopes Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Therapeutic Radioisotopes Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Therapeutic Radioisotopes Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Therapeutic Radioisotopes Sales, Consumption, Export, Import (2016-2021)
4.10 South America Therapeutic Radioisotopes Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Therapeutic Radioisotopes Market Analysis
5.1 North America Therapeutic Radioisotopes Consumption and Value Analysis
5.1.1 North America Therapeutic Radioisotopes Market Under COVID-19
5.2 North America Therapeutic Radioisotopes Consumption Volume by Types
5.3 North America Therapeutic Radioisotopes Consumption Structure by Application
5.4 North America Therapeutic Radioisotopes Consumption by Top Countries
5.4.1 United States Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
5.4.2 Canada Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
5.4.3 Mexico Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
Chapter 6 East Asia Therapeutic Radioisotopes Market Analysis
6.1 East Asia Therapeutic Radioisotopes Consumption and Value Analysis
6.1.1 East Asia Therapeutic Radioisotopes Market Under COVID-19
6.2 East Asia Therapeutic Radioisotopes Consumption Volume by Types
6.3 East Asia Therapeutic Radioisotopes Consumption Structure by Application
6.4 East Asia Therapeutic Radioisotopes Consumption by Top Countries
6.4.1 China Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
6.4.2 Japan Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
6.4.3 South Korea Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
Chapter 7 Europe Therapeutic Radioisotopes Market Analysis
7.1 Europe Therapeutic Radioisotopes Consumption and Value Analysis
7.1.1 Europe Therapeutic Radioisotopes Market Under COVID-19
7.2 Europe Therapeutic Radioisotopes Consumption Volume by Types
7.3 Europe Therapeutic Radioisotopes Consumption Structure by Application
7.4 Europe Therapeutic Radioisotopes Consumption by Top Countries
7.4.1 Germany Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
7.4.2 UK Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
7.4.3 France Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
7.4.4 Italy Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
7.4.5 Russia Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
7.4.6 Spain Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
7.4.7 Netherlands Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
7.4.8 Switzerland Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
7.4.9 Poland Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
Chapter 8 South Asia Therapeutic Radioisotopes Market Analysis
8.1 South Asia Therapeutic Radioisotopes Consumption and Value Analysis
8.1.1 South Asia Therapeutic Radioisotopes Market Under COVID-19
8.2 South Asia Therapeutic Radioisotopes Consumption Volume by Types
8.3 South Asia Therapeutic Radioisotopes Consumption Structure by Application
8.4 South Asia Therapeutic Radioisotopes Consumption by Top Countries
8.4.1 India Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
8.4.2 Pakistan Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Therapeutic Radioisotopes Market Analysis
9.1 Southeast Asia Therapeutic Radioisotopes Consumption and Value Analysis
9.1.1 Southeast Asia Therapeutic Radioisotopes Market Under COVID-19
9.2 Southeast Asia Therapeutic Radioisotopes Consumption Volume by Types
9.3 Southeast Asia Therapeutic Radioisotopes Consumption Structure by Application
9.4 Southeast Asia Therapeutic Radioisotopes Consumption by Top Countries
9.4.1 Indonesia Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
9.4.2 Thailand Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
9.4.3 Singapore Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
9.4.4 Malaysia Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
9.4.5 Philippines Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
9.4.6 Vietnam Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
9.4.7 Myanmar Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
Chapter 10 Middle East Therapeutic Radioisotopes Market Analysis
10.1 Middle East Therapeutic Radioisotopes Consumption and Value Analysis
10.1.1 Middle East Therapeutic Radioisotopes Market Under COVID-19
10.2 Middle East Therapeutic Radioisotopes Consumption Volume by Types
10.3 Middle East Therapeutic Radioisotopes Consumption Structure by Application
10.4 Middle East Therapeutic Radioisotopes Consumption by Top Countries
10.4.1 Turkey Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
10.4.3 Iran Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
10.4.5 Israel Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
10.4.6 Iraq Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
10.4.7 Qatar Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
10.4.8 Kuwait Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
10.4.9 Oman Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
Chapter 11 Africa Therapeutic Radioisotopes Market Analysis
11.1 Africa Therapeutic Radioisotopes Consumption and Value Analysis
11.1.1 Africa Therapeutic Radioisotopes Market Under COVID-19
11.2 Africa Therapeutic Radioisotopes Consumption Volume by Types
11.3 Africa Therapeutic Radioisotopes Consumption Structure by Application
11.4 Africa Therapeutic Radioisotopes Consumption by Top Countries
11.4.1 Nigeria Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
11.4.2 South Africa Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
11.4.3 Egypt Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
11.4.4 Algeria Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
11.4.5 Morocco Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
Chapter 12 Oceania Therapeutic Radioisotopes Market Analysis
12.1 Oceania Therapeutic Radioisotopes Consumption and Value Analysis
12.2 Oceania Therapeutic Radioisotopes Consumption Volume by Types
12.3 Oceania Therapeutic Radioisotopes Consumption Structure by Application
12.4 Oceania Therapeutic Radioisotopes Consumption by Top Countries
12.4.1 Australia Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
12.4.2 New Zealand Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
Chapter 13 South America Therapeutic Radioisotopes Market Analysis
13.1 South America Therapeutic Radioisotopes Consumption and Value Analysis
13.1.1 South America Therapeutic Radioisotopes Market Under COVID-19
13.2 South America Therapeutic Radioisotopes Consumption Volume by Types
13.3 South America Therapeutic Radioisotopes Consumption Structure by Application
13.4 South America Therapeutic Radioisotopes Consumption Volume by Major Countries
13.4.1 Brazil Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
13.4.2 Argentina Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
13.4.3 Columbia Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
13.4.4 Chile Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
13.4.5 Venezuela Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
13.4.6 Peru Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
13.4.8 Ecuador Therapeutic Radioisotopes Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Therapeutic Radioisotopes Business
14.1 Bayer
14.1.1 Bayer Company Profile
14.1.2 Bayer Therapeutic Radioisotopes Product Specification
14.1.3 Bayer Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Novartis
14.2.1 Novartis Company Profile
14.2.2 Novartis Therapeutic Radioisotopes Product Specification
14.2.3 Novartis Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 China Isotope & Radiation
14.3.1 China Isotope & Radiation Company Profile
14.3.2 China Isotope & Radiation Therapeutic Radioisotopes Product Specification
14.3.3 China Isotope & Radiation Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Dongcheng
14.4.1 Dongcheng Company Profile
14.4.2 Dongcheng Therapeutic Radioisotopes Product Specification
14.4.3 Dongcheng Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Q BioMed
14.5.1 Q BioMed Company Profile
14.5.2 Q BioMed Therapeutic Radioisotopes Product Specification
14.5.3 Q BioMed Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Curium Pharmaceuticals
14.6.1 Curium Pharmaceuticals Company Profile
14.6.2 Curium Pharmaceuticals Therapeutic Radioisotopes Product Specification
14.6.3 Curium Pharmaceuticals Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Jubilant DraxImage
14.7.1 Jubilant DraxImage Company Profile
14.7.2 Jubilant DraxImage Therapeutic Radioisotopes Product Specification
14.7.3 Jubilant DraxImage Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Lantheus
14.8.1 Lantheus Company Profile
14.8.2 Lantheus Therapeutic Radioisotopes Product Specification
14.8.3 Lantheus Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Spectrum Pharmaceuticals
14.9.1 Spectrum Pharmaceuticals Company Profile
14.9.2 Spectrum Pharmaceuticals Therapeutic Radioisotopes Product Specification
14.9.3 Spectrum Pharmaceuticals Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Progenics Pharmaceuticals
14.10.1 Progenics Pharmaceuticals Company Profile
14.10.2 Progenics Pharmaceuticals Therapeutic Radioisotopes Product Specification
14.10.3 Progenics Pharmaceuticals Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 International Isotopes
14.11.1 International Isotopes Company Profile
14.11.2 International Isotopes Therapeutic Radioisotopes Product Specification
14.11.3 International Isotopes Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Therapeutic Radioisotopes Market Forecast (2022-2027)
15.1 Global Therapeutic Radioisotopes Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Therapeutic Radioisotopes Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Therapeutic Radioisotopes Value and Growth Rate Forecast (2022-2027)
15.2 Global Therapeutic Radioisotopes Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Therapeutic Radioisotopes Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Therapeutic Radioisotopes Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Therapeutic Radioisotopes Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Therapeutic Radioisotopes Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Therapeutic Radioisotopes Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Therapeutic Radioisotopes Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Therapeutic Radioisotopes Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Therapeutic Radioisotopes Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Therapeutic Radioisotopes Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Therapeutic Radioisotopes Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Therapeutic Radioisotopes Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Therapeutic Radioisotopes Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Therapeutic Radioisotopes Consumption Forecast by Type (2022-2027)
15.3.2 Global Therapeutic Radioisotopes Revenue Forecast by Type (2022-2027)
15.3.3 Global Therapeutic Radioisotopes Price Forecast by Type (2022-2027)
15.4 Global Therapeutic Radioisotopes Consumption Volume Forecast by Application (2022-2027)
15.5 Therapeutic Radioisotopes Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
